We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Incubation Period for Mad Cow Disease May Be 60 Years

By Biotechdaily staff writers
Posted on 07 Jul 2006
New findings show that the incubation period for variant Creutzfeldt-Jakob (vCJD) disease in humans, the human form of mad cow disease, may be much longer than supposed, perhaps as long as 60 years or more.

Researchers from the University College of London (UCL, UK) identified a prion disease called kuru among the people of New Guinea that occurred mainly in women and children who took part in funeral feasts that included the brains of relatives. More...
Boys older than eight customarily did not take part in these feasts.

The researchers took histories of residence and participation in funereal feasts and combined the information with data from serial neurologic examinations, when available. In all, they identified 11 patients, seven man and four women, with kuru. All of them were born before the practice of including brains in the funeral feasts was stopped in the 1950s. The researchers used experimental, epidemiologic, and human behavioral evidence to conclude that the practice had definitely stopped by 1960.

"Therefore, we could define the minimum incubation period as the time between 1960 and the date of onset of kuru,” wrote the researchers.

The seven patients were born between 1933 and 1949, and ranged from 46 to 62 years old at the time of disease onset. Based on all their data, the researchers determined that the minimum estimated incubation period ranged from 34-41 years. The incubation period in men who only took part in the funeral feasts when very young may have been 39-56 years or even 63 years, according to the investigators.

Eight of the 10 patients for whom genetic data were available were heterozygous for a polymorphism associated with extended incubation periods and resistance to prion diseases.

These findings suggest that an epidemic of variant CJD could show up many years from now, parallel with the aging of people who consumed beef from cows with bovine spongiform encephalopathy (BSE) back in the 1990s. The results were published in the June 24 issue of The Lancet.



Related Links:
University College, London

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.